Home » Newsletters » BioWorld Science

BioWorld Science

March 9, 2000

View Archived Issues

Pentacea enters phase I/II trials as solid tumor therapy; receives orphan drug designation

Medicure receives second U.S. patent for cardiovascular drug

Shire updates R&D progress for year-end 1999

Cubist presents phase II data for daptomycin

KR-30035, an improved MDR modulator from the verapamil class

AGE crosslink breaker effective in nondiabetic animals with myocardial stiffness

Abbott acquires exclusive marketing rights for Actos in Latin America from Takeda

Nabi and the NIDA begin toxicity studies of Nabi-NicVAX

Dexanabinol successfully completes phase II trials

White House teams up with industry to launch the Millennium Vaccine Initiative

BTG outlicenses factor IX gene to Avigen

InKine initiates pharmacokinetic study of tablet formulation of CBP-1011

SmithKline Beecham reaffirms commitment to preventing, treating diseases in the developing world

Solid oral formulations of eprosartan with enhanced bioavailability

Antitumor/antiallergic agents discovered at Teijin

Esters providing sustained release of MDL-100907 prepared at Aventis

Taisho presents new interleukin production inhibitors with nitroaniline structure

Prostanoid receptor ligands with selectivity for EP4 receptors designed by Ono researchers

FDA grants fast track status to arsenic trioxide

Yamanouchi exercises option to license three Searle compounds

Injectable carvedilol formulations successfully developed

Yamanouchi begins rolling out Infergen in new markets

Immtech scales up production of DB-289; initiation of phase I testing later this year

Inducer of phenotypic reversion; isolation, structure and activity of new trichostatin

Dynavax's ragweed immunotherapy has improved safety according to preclinical and clinical data

The FDA approves once-daily Singulair tablet for treatment of asthma in young children

Long-term bosentan therapy attenuates progression of LV dysfunction and remodeling in heart failure

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...